A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at Los Angeles, California and other locations
- Dates
- study startedcompletion around
- Principal Investigator
- by Edmund Tsui, MD

Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCLA
- Edmund Tsui, MD
Associate Professor-in-residence, Ophthalmology, Medicine. Authored (or co-authored) 87 research publications
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Priovant Therapeutics, Inc.
- Links
- Related Info Sign up for this study
- ID
- NCT06431373
- Phase
- Phase 3 Uveitis Research Study
- Study Type
- Interventional
- Participants
- Expecting 300 study participants
- Last Updated